Direct screening of plasma circulating microRNAs

RNA Biol. 2018;15(10):1268-1272. doi: 10.1080/15476286.2018.1526538. Epub 2018 Oct 9.

Abstract

Circulating microRNAs (miRNAs) are considered as reliable candidates for biomarker discovery. RNA-Sequencing has become the most suitable technique to accurately quantify the miRNAome. However, RNA-Sequencing relies on several technical passages before reaching the final-end. HTG EdgeSeq technology, thanks to the abrogation of RNA extraction step, allows productivity enhancement by reducing the number of hands-on steps, the time for sample preparation and, therefore, the costs. We found a strong correlation between qPCR and dPCR with HTG (Pearson's coefficient of 0.93 and 0.94, respectively). In conclusion, we showed that HTG EdgeSeq, performed on human plasma specimens without RNA extraction, is reliable, allows the simultaneous screening of more than 2,000 miRNAs, and thus, it could be applied to biomarker discovery in large cohorts.

Keywords: HTG EdgeSeq; digital PCR; direct quantification; miRNAome; quantitative PCR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood*
  • Circulating MicroRNA / blood*
  • Circulating MicroRNA / genetics
  • Humans
  • MicroRNAs / blood*
  • MicroRNAs / genetics
  • Sequence Analysis, RNA*

Substances

  • Biomarkers
  • Circulating MicroRNA
  • MicroRNAs

Grants and funding

This work was supported by the Fondazione Gigi e Pupa Ferrari [FPF-14]; Ministero della Salute [RC2016-BIO34-2627243].